Inventor · disambiguated record
Renate Sekul
Also filed as: SEKUL RENATE
29 granted patents·11 pending applications·1,674 citations·filing 1997–2018
98Inventor score
Top patents by PatentIndex Score
40 records- 0198US6037323AApolipoprotein A-I agonists and their use to treat dyslipidemic disordersDASSEUX JEAN LOUIS·Filed 1997·Granted Mar 14, 2000·298 cites·54 claims
- 0297US6046166AApolipoprotein A-I agonists and their use to treat dyslipidemic disordersDASSEUX JEAN LOUIS·Filed 1997·Granted Apr 4, 2000·192 cites·49 claims
- 0396US6376464B1Lipid complexes of APO A-1 agonist compoundsDASSEUX JEAN-LOUIS·Filed 1999·Granted Apr 23, 2002·116 cites·21 claims
- 0496US6004925AApolipoprotein A-I agonists and their use to treat dyslipidemic disordersDASSEUX J L·Filed 1997·Granted Dec 21, 1999·265 cites·58 claims
- 0595US6734169B2Apolipoprotein A-I agonists and their use to treat dyslipidemic disordersDASSEUX JEAN LOUIS·Filed 2001·Granted May 11, 2004·68 cites·27 claims
- 0694US6602854B1Branched multimeric Apo A-I agonist compoundsFiled 1999·Granted Aug 5, 2003·79 cites·38 claims
- 0793US6753313B1Multimeric Apoa-I agonist compoundsFiled 1999·Granted Jun 22, 2004·73 cites·48 claims
- 0893US6265377B1Apolipoprotein A-I agonists and their use to treat dyslipidemic disordersFiled 1999·Granted Jul 24, 2001·83 cites·48 claims
- 0992US6573239B1Apolipoprotein A-I agonist compoundsFiled 1999·Granted Jun 3, 2003·62 cites·34 claims
- 1091US7956191B23-arylamino pyridine derivativesMERCK SERONO SA·Filed 2005·Granted Jun 7, 2011·19 cites·9 claims
- 1191US6844327B2Gene therapy approaches to supply apolipoprotein A-I agonists and their use to treat dyslipidemic disordersFiled 2002·Granted Jan 18, 2005·28 cites·23 claims
- 1291US6630450B1Method of treating dyslipidemiaFiled 1999·Granted Oct 7, 2003·58 cites·36 claims
- 1391US6329341B1Method of treating septic shockESPERION THERAPEUTICS INC·Filed 1999·Granted Dec 11, 2001·61 cites·21 claims
- 1490US6716816B1Multimeric Apo A-I agonist compoundsFiled 1999·Granted Apr 6, 2004·52 cites·58 claims
- 1589US7566695B2Multimeric apoprotein agonistsPFIZER·Filed 2006·Granted Jul 28, 2009·9 cites·8 claims
- 1689US6518412B1Gene therapy approaches to supply apolipoprotein A-I agonists and their use to treat dyslipidemic disordersFiled 1997·Granted Feb 11, 2003·64 cites·9 claims
- 1788US7189689B2Apolipoprotein A-L agonists and their use to treat dyslipidemic disordersDASSEUX JEAN-LOUIS·Filed 2002·Granted Mar 13, 2007·17 cites·19 claims
- 1887US7211565B2Apolipoprotein A-I agonists and their use to treat dyslipidemic disordersDASSEUX JEAN-LOUIS·Filed 2004·Granted May 1, 2007·19 cites·30 claims
- 1986US7312190B2Pharmaceutical compositions of apolipoprotein A-I agonists and their use to treat dyslipidemic disordersDASSEUX JEAN-LOUIS·Filed 2004·Granted Dec 25, 2007·13 cites·11 claims
- 2085US8198457B23-arylamino pyridine derivativesABEL ULRICH·Filed 2011·Granted Jun 12, 2012·8 cites·12 claims
- 2185US7307058B2Multimeric Apo A-I agonist compoundsDASSEUX JEAN-LOUIS·Filed 2003·Granted Dec 11, 2007·11 cites·23 claims
- 2285US7250407B2Gene therapy approaches to supply apolipoprotein A-I agonists and their use to treat dyslipidemic disordersPFIZER·Filed 2004·Granted Jul 31, 2007·16 cites·14 claims
- 2384US8841459B23-arylamino pyridine derivativesMERCK SERONO SA·Filed 2013·Granted Sep 23, 2014·6 cites·18 claims
- 2483US8524911B23-arylamino pyridine derivativesABEL ULRICH·Filed 2012·Granted Sep 3, 2013·6 cites·6 claims
- 2583US7273848B2Apolipoprotein A-I agonists and their use to treat dyslipidemic disordersDASSEUX JEAN-LOUIS·Filed 2004·Granted Sep 25, 2007·12 cites·23 claims
- 2682US7157425B2Apolipoprotein A-I agonists and their use to treat dyslipidemic disordersDASSEUX JEAN-LOUIS·Filed 2002·Granted Jan 2, 2007·12 cites·17 claims
- 2776US6900177B1Apolipoprotein A-I agonists and their use to treat dyslipidemic disordersFiled 1999·Granted May 31, 2005·27 cites·26 claims
- 2862US2008058270A1Apolipoprotein A-I agonists and their use to treat dyslipidemic disordersDASSEUX JEAN-LOUIS·Filed 2007·Application pending·0 cites
- 2962US2008050351A1Gene Therapy Approaches to Supply Apolipoprotein A-I Agonists and Their Use to Treat Dyslipidemic DisorderPFIZER·Filed 2007·Application pending·0 cites
- 3052US7955638B2Surface for the immobilization of ligandsGRAFFINITY PHARMACEUTICALS AG·Filed 2007·Granted Jun 7, 2011·0 cites·16 claims
- 3146US2020325183A1Ns2b as marker for zika virus infectionsPEPperPRINT GmbH·Filed 2018·Application pending·0 cites
- 3244US2005153357A1Bioactive sensorsFiled 2005·Application pending·0 cites
- 3344US2017334948A1Ligands for antibody and fc-fusion protein purification by affinity chromotography ivNOVALIX DEUTSCHLAND GMBH·Filed 2017·Application pending·0 cites
- 3443US9745339B2Ligands for antibody and Fc-fusion protein purification by affinity chromotography IVGRAFFINITY PHARMACEUTICALS GMBH·Filed 2013·Granted Aug 29, 2017·0 cites·16 claims
- 3543US2017152288A1LIGANDS FOR ANTIBODY AND Fc-FUSION PROTEIN PURIFICATION BY AFFINITY CHROMATOGRAPHYNOVALIX DEUTSCHLAND GMBH·Filed 2017·Application pending·0 cites
- 3643US2013131321A1LIGANDS FOR ANTIBODY AND Fc-FUSION PROTEIN PURIFICATION BY AFFINITY CHROMATOGRAPHYBITTERMANN HOLGER·Filed 2011·Application pending·0 cites
- 3740US2004235146A9Surface for the immobilization of ligandsFiled 2001·Application pending·0 cites
- 3839US2002127577A1Bioactive sensorsFiled 2001·Application pending·0 cites
- 3939US2004082079A1Low affinity screening methodFiled 2002·Application pending·0 cites
- 4038US2004248111A1Screening method using solid supports modified with self-assembled monolayersFiled 2002·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →